Clinicopathologic risk factors like age, sex, obesity, family history and expert pathology have been shown to have limited ability to predict progression to esophageal cancer. TissueCypher outperforms these risk factors and provides physicians with an actionable risk score and the patient’s personalized 5-year risk of progression.